Suppr超能文献

接受根治性子宫切除术和盆腔外照射治疗的早期宫颈癌患者的复发模式。

Recurrence patterns in patients with early stage cervical cancer treated with radical hysterectomy and external pelvic irradiation.

作者信息

Gadducci A, Fabrini M G, Bonuccelli A, Fanucchi A, Perutelli A, Facchini V

机构信息

Department of Gynecology and Obstetrics, University of Pisa, Italy.

出版信息

Anticancer Res. 1995 May-Jun;15(3):1071-7.

PMID:7645928
Abstract

One hundred and fifty patients with clinical FIGO stage IB-II cervical cancer who underwent radical surgery followed by external pelvic irradiation between 1978 and 1991 were reviewed. Until June 1994, 28 (18.7%) patients developed recurrent disease. Seventeen (60.7%) of them experienced a pelvic failure, 7 (25.0%) an extrapelvic failure and 4 (14.3%) both a pelvic and an extrapelvic failure. The median time to recurrence was 16 months for patients with pelvic failure (range = 4-50 months), 27 months for those with extrapelvic failure (range = 6-49 months), and 21 months for those with both pelvic and extrapelvic failure (range u 8-56 months). Recurrence rates were significantly related to surgical-pathologic stage, tumor size and lymph node status, but not to histologic type. An extrapelvic recurrence, alone or associated with a pelvic failure, was found in 0.9% of 117 patients with negative lymph nodes, 6.2% of 16 patients with one or two positive lymph nodes, and 52.9% of 17 patients with three or more positive lymph nodes, (p = 0.0001). It is worth noting that 9 (81.8%) out of the 11 patients who developed extrapelvic recurrences had three or more involved lymph nodes. The number of positive lymph nodes (p = 0.0001) and the tumor size (p = 0.0046) were independent prognostic variables for disease-free survival.

摘要

对1978年至1991年间接受根治性手术并随后进行盆腔外照射的150例临床FIGO分期为IB-II期宫颈癌患者进行了回顾性研究。截至1994年6月,28例(18.7%)患者出现复发疾病。其中17例(60.7%)出现盆腔复发,7例(25.0%)出现盆腔外复发,4例(14.3%)盆腔和盆腔外均复发。盆腔复发患者的复发中位时间为16个月(范围=4 - 50个月),盆腔外复发患者为27个月(范围=6 - 49个月),盆腔和盆腔外均复发患者为21个月(范围=8 - 56个月)。复发率与手术病理分期、肿瘤大小和淋巴结状态显著相关,但与组织学类型无关。在117例淋巴结阴性的患者中,0.9%出现盆腔外复发,单独或合并盆腔复发;在16例有1或2个阳性淋巴结的患者中,6.2%出现盆腔外复发;在17例有3个或更多阳性淋巴结的患者中,52.9%出现盆腔外复发,(p = 0.0001)。值得注意的是,在发生盆腔外复发的11例患者中,9例(81.8%)有3个或更多受累淋巴结。阳性淋巴结数量(p = 0.0001)和肿瘤大小(p = 0.0046)是无病生存的独立预后变量。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验